Black Bird Biotech, Inc.: 10-Q filed 2015-11-06

Name: Black Bird Biotech, Inc.: 10-Q filed 2015-11-06
Creator: Black Bird Biotech, Inc.
License: https://creativecommons.org/licenses/by/4.0/

What Black Bird Biotech, Inc. reported in its quarterly report filed 2015-11-06 (fiscal Q3 2015): 10 published measures, 28 facts as tagged in accession 0001144204-15-063245.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-11-06
Fiscal period: fiscal Q3 2015
Accession: 0001144204-15-063245 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Black Bird Biotech, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-09-30	10,824	USD
At 2014-12-31	22,628	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-09-30	661,037	USD
At 2014-12-31	591,594	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-09-30	-650,213	USD
At 2014-12-31	-568,966	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-23,675	USD	92
2015-01-01 to 2015-09-30	-81,247	USD	273
2014-07-01 to 2014-09-30	-24,574	USD	92
2014-01-01 to 2014-09-30	-77,417	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-09-30	-8,225,130	USD
At 2014-12-31	-8,143,883	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-16,912	USD	92
2015-01-01 to 2015-09-30	-61,679	USD	273
2014-07-01 to 2014-09-30	-18,767	USD	92
2014-01-01 to 2014-09-30	-60,763	USD	273

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	6,763	USD	92
2015-01-01 to 2015-09-30	19,568	USD	273
2014-07-01 to 2014-09-30	5,807	USD	92
2014-01-01 to 2014-09-30	16,654	USD	273

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-09-30	111,037	USD
At 2014-12-31	91,594	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	16,912	USD	92
2015-01-01 to 2015-09-30	61,679	USD	273
2014-07-01 to 2014-09-30	18,767	USD	92
2014-01-01 to 2014-09-30	60,763	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-09-30	85,970,665	shares
At 2014-12-31	85,970,665	shares

Inspect the source

Entity: Black Bird Biotech, Inc. / CIK 0001409999
Captured: 2026-09-22 19:47 UTC
SEC response SHA-256: df936db10ff162447a769152b36bd1ddff9f21ac96d53dd4e87253b660581055

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001409999.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))